Correlation of PSMA-Targeted 18F-DCFPyL PET/CT Findings With Immunohistochemical and Genomic Data in a Patient With Metastatic Neuroendocrine Prostate Cancer

Jeffrey J. Tosoian; Michael A. Gorin; Steven P. Rowe; Darian Andreas; Zsolt Szabo; Kenneth J. Pienta; Martin G. Pomper; Tamara L. Lotan; Ashley E. Ross

doi:10.1016/j.clgc.2016.09.002

Correlation of PSMA-Targeted ¹⁸F-DCFPyL PET/CT Findings With Immunohistochemical and Genomic Data in a Patient With Metastatic Neuroendocrine Prostate Cancer

Jeffrey J. Tosoian^*, Michael A. Gorin, Steven P. Rowe, Darian Andreas, Zsolt Szabo, Kenneth J. Pienta, Martin G. Pomper, Tamara L. Lotan, Ashley E. Ross

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

50 Scopus citations

Original language	English (US)
Pages (from-to)	e65-e68
Journal	Clinical Genitourinary Cancer
Volume	15
Issue number	1
DOIs	https://doi.org/10.1016/j.clgc.2016.09.002
State	Published - Feb 1 2017
Externally published	Yes

Keywords

Immunohistochemistry (IHC)
Metastatic prostate cancer
Neuroendocrine prostate cancer
Positron emission tomography/computed tomography (PET/CT) imaging
Prostate-specific membrane antigen

ASJC Scopus subject areas

Oncology
Urology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.clgc.2016.09.002

Cite this

Tosoian, J. J., Gorin, M. A., Rowe, S. P., Andreas, D., Szabo, Z., Pienta, K. J., Pomper, M. G., Lotan, T. L., & Ross, A. E. (2017). Correlation of PSMA-Targeted ¹⁸F-DCFPyL PET/CT Findings With Immunohistochemical and Genomic Data in a Patient With Metastatic Neuroendocrine Prostate Cancer. Clinical Genitourinary Cancer, 15(1), e65-e68. https://doi.org/10.1016/j.clgc.2016.09.002

@article{65c0ff4922e146b0bd3eb97e91a2ae9b,

title = "Correlation of PSMA-Targeted 18F-DCFPyL PET/CT Findings With Immunohistochemical and Genomic Data in a Patient With Metastatic Neuroendocrine Prostate Cancer",

keywords = "Immunohistochemistry (IHC), Metastatic prostate cancer, Neuroendocrine prostate cancer, Positron emission tomography/computed tomography (PET/CT) imaging, Prostate-specific membrane antigen",

author = "Tosoian, {Jeffrey J.} and Gorin, {Michael A.} and Rowe, {Steven P.} and Darian Andreas and Zsolt Szabo and Pienta, {Kenneth J.} and Pomper, {Martin G.} and Lotan, {Tamara L.} and Ross, {Ashley E.}",

year = "2017",

month = feb,

day = "1",

doi = "10.1016/j.clgc.2016.09.002",

language = "English (US)",

volume = "15",

pages = "e65--e68",

journal = "Clinical Genitourinary Cancer",

issn = "1558-7673",

publisher = "Elsevier",

number = "1",

}

Tosoian, JJ, Gorin, MA, Rowe, SP, Andreas, D, Szabo, Z, Pienta, KJ, Pomper, MG, Lotan, TL & Ross, AE 2017, 'Correlation of PSMA-Targeted ¹⁸F-DCFPyL PET/CT Findings With Immunohistochemical and Genomic Data in a Patient With Metastatic Neuroendocrine Prostate Cancer', Clinical Genitourinary Cancer, vol. 15, no. 1, pp. e65-e68. https://doi.org/10.1016/j.clgc.2016.09.002

TY - JOUR

T1 - Correlation of PSMA-Targeted 18F-DCFPyL PET/CT Findings With Immunohistochemical and Genomic Data in a Patient With Metastatic Neuroendocrine Prostate Cancer

AU - Tosoian, Jeffrey J.

AU - Gorin, Michael A.

AU - Rowe, Steven P.

AU - Andreas, Darian

AU - Szabo, Zsolt

AU - Pienta, Kenneth J.

AU - Pomper, Martin G.

AU - Lotan, Tamara L.

AU - Ross, Ashley E.

PY - 2017/2/1

Y1 - 2017/2/1

KW - Immunohistochemistry (IHC)

KW - Metastatic prostate cancer

KW - Neuroendocrine prostate cancer

KW - Positron emission tomography/computed tomography (PET/CT) imaging

KW - Prostate-specific membrane antigen

UR - http://www.scopus.com/inward/record.url?scp=85001831561&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85001831561&partnerID=8YFLogxK

U2 - 10.1016/j.clgc.2016.09.002

DO - 10.1016/j.clgc.2016.09.002

M3 - Article

C2 - 27751686

AN - SCOPUS:85001831561

SN - 1558-7673

VL - 15

SP - e65-e68

JO - Clinical Genitourinary Cancer

JF - Clinical Genitourinary Cancer

IS - 1

ER -